Enterohemorrhagic and other Shigatoxin-producing Escherichia coli - Escherichia coli: Pathotypes and Principles of Pathogenesis - page 156

Gao, X., Wan, F., Mateo, K., et al., 2009. Bacterial effector binding to ribosomal protein s3 subverts
NF-kappaB function. PLoS Pathog. 5 (12), e1000708 .
Garmendia, J., Carlier, M.F., Egile, C., et al., 2006. Characterization of TccP-mediated N-WASP
activation during enterohaemorrhagic Escherichia coli infection. Cell Microbiol. 8 (9), 1444-1455 .
Garmendia, J., Frankel, G., Crepin, V.F., 2005. Enteropathogenic and enterohemorrhagic Escherichia
coli infections: translocation, translocation, translocation. Infect. Immun. 73 (5), 2573-2585 .
Garmendia, J., Phillips, A.D., Carlier, M.F., et al., 2004. TccP is an enterohaemorrhagic Escherichia
coli O157:H7 type III effector protein that couples Tir to the actin-cytoskeleton. Cell Microbiol.
6 (12), 1167-1183 .
Garred, O., Dubinina, E., Holm, P.K., et al., 1995a. Role of processing and intracellular transport for
optimal toxicity of Shiga toxin and toxin mutants. Exp. Cell Res. 218 (1), 39-49 .
Garred, O., Dubinina, E., Polesskaya, A., et al., 1997. Role of the disulide bond in Shiga toxin
A-chain for toxin entry into cells. J. Biol. Chem. 272 (17), 11414-11419 .
Garred, O., van Deurs, B., Sandvig, K., 1995b. Furin-induced cleavage and activation of Shiga
toxin. J. Biol. Chem. 270 (18), 10817-10821 .
Geelen, J., Valsecchi, F., van der Velden, T., et al., 2008. Shiga-toxin-induced irm adhesion of human
leukocytes to endothelium is in part mediated by heparan sulfate. Nephrol. Dial Transplant 23 (10),
3091-3095 .
George Morris Study Excerpt, 2007. Cost of E. coli O157:H7 illness in Canada. www.fightecoli.
com/docs/MorrisReportExcerpt-en.pdf.
Ghosh, S.A., Polanowska-Grabowska, R.K., Fujii, J., et al., 2004. Shiga toxin binds to activated
platelets. J. Thromb. Haemost. 2 (3), 499-506 .
Girard, F., Batisson, I., Frankel, G.M., et al., 2005. Interaction of enteropathogenic and Shiga toxin-
producing Escherichia coli and porcine intestinal mucosa: role of intimin and Tir in adherence.
Infect. Immun. 73 (9), 6005-6016 .
Girod, A., Storrie, B., Simpson, J.C., et al., 1999. Evidence for a COP-I-independent transport route
from the Golgi complex to the endoplasmic reticulum. Nat. Cell Biol. 1 (7), 423-430 .
Goley, E.D., Welch, M.D., 2006. The ARP2/3 complex: an actin nucleator comes of age. Nat. Rev.
Mol. Cell Biol. 7 (10), 713-726 .
Grifin, P.M., Olmstead, L.C., Petras, R.E., 1990. Escherichia coli O157:H7-associated colitis. A
clinical and histological study of 11 cases. Gastroenterology 99 (1), 142-149 .
Grifin, P.M., Tauxe, R.V., 1991. The epidemiology of infections caused by Escherichia coli
O157:H7, other enterohemorrhagic E. coli , and the associated hemolytic uremic syndrome.
Epidemiol. Rev. 13, 60-98 .
Gruppo, R.A., Rother, R.P., 2009. Eculizumab for congenital atypical hemolytic-uremic syndrome.
N. Engl. J. Med. 360 (5), 544-546 .
Grys, T.E., Siegel, M.B., Lathem, W.W., et al., 2005. The StcE protease contributes to intimate adherence
of enterohemorrhagic Escherichia coli O157:H7 to host cells. Infect. Immun. 73 (3), 1295-1303 .
Grys, T.E., Walters, L.L., Welch, R.A., 2006. Characterization of the StcE protease activity of
Escherichia coli O157:H7. J. Bacteriol. 188 (13), 4646-4653 .
Guh, A., Phan, Q., Nelson, R., et al., 2010. Outbreak of Escherichia coli O157 associated with raw
milk, Connecticut, 2008. Clin. Infect. Dis. 51 (12), 1411-1417 .
Gupta, P., Singh, M.K., Singh, Y., et al., 2011. Recombinant Shiga toxin B subunit elicits protection
against Shiga toxin via mixed Th type immune response in mice. Vaccine 29 (45), 8094-8100 .
Guttman, J.A., Finlay, B.B., 2008. Subcellular alterations that lead to diarrhea during bacterial
pathogenesis. Trends Microbiol. 16 (11), 535-542 .
Guttman, J.A., Li, Y., Wickham, M.E., et al., 2006a. Attaching and effacing pathogen-induced tight
junction disruption in vivo . Cell Microbiol. 8 (4), 634-645 .